Oxford BioMedica PLC (OXB)

Industry Biotechnology

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

629.00p

Buy

635.00p

arrow-down-15.00p (-2.34%)

Prices updated at 12 Dec 2025, 17:00 GMT

Prices minimum 15 mins delay

Prices in GBX

Oxford BioMedica PLC is a biopharmaceutical company based in the United Kingdom. It develops gene and cell therapy product candidates in the areas of oncology, ophthalmology and CNS disorders.

FTSE All-Share

-0.48%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2023	2024
	90m	129m
	40m	53m
	-88m	-44m
	-98.40	-33.78
	-157m	-43m
	-149m	-14m
Sales, General and administrative	27m	29m
Interest expenses	11m	11m
Provision for income taxes	-4m	1m
Operating expenses	128m	97m
Income before taxes	-189m	-47m
Net income available to common shareholders	-157m	-43m
	-1.6311	-0.4175
Net interest income	-6m	-7m
Advertising and promotion	-	-
Net investment income, net	2m	-621,000
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	-1.6311	-0.4175
Free cash flow per share	-0.0898	-0.7146
Book value/share	1.7779	0.6253
Debt equity ratio	1.456693	1.829068

Balance sheet

Year chevron-l-regular chevron-r-regular	2023	2024
Current assets	141m	133m
Current liabilities	44m	58m
Total capital	113m	97m
Total debt	111m	109m
Total equity	74m	57m
Total non current liabilities	-	-
Loans	39m	40m
Total assets	252m	232m
Total liabilities	-	-
Cash and cash equivalents	104m	61m
Common stock	97m	106m

Cash flow

Year chevron-l-regular chevron-r-regular	2023	2024
Cash at beginning of period	141m	104m
Cash dividends paid	-	-
	-38m	-58m
Investments (gains) losses	3m	6m
	104m	61m
Net income	-	-
	-29m	-51m
	-10m	-7m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.